Frost & Sullivan

The Most Effective Way to Identify Better Outcomes When Using Limited Patient Populations

Patients with rare diseases are often underdiagnosed, misdiagnosed, or have yet to begin therapy as a result of complicating diagnostic factors. Most commercial healthcare databases lack the predictability needed to identify patients who are receiving or could receive novel therapies. Identifying predictable patterns in the patient journey signals can help commercial teams focus on patients where they can make a difference sooner.

Clinical Alerts

Download this complimentary executive brief to discover:

  • Mapping the healthcare journey
  • New methodologies and data mining approaches
  • Utilizing advanced analytics to identify signals
  • Criteria to evaluate mapping vendors of patient encounter data